OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 30, 2021
BIA and Clarivate have released data showing that UK biotech companies are set to experience another strong year for fundraising in 2021.
March 29, 2021
The need for added revenues to fund billion-dollar infrastructure improvements has fueled challenges to industry pricing practices.
March 17, 2021
The Federal Trade Commission is launching a broad review of drug-company mergers, with an eye to examining how such actions can harm competition in the biopharmaceutical industry.
March 16, 2021
Many biologic drug manufacturers encounter similiar challenges; precompetitive collaboration can help resolve these issues. Representatives of the IQ Consortium’s Biologics CMC Leadership Group describe efforts to address the safe handling of biologic drugs in closed-system transfer devices in healthcare settings and the need for phase-appropriate specifications.
March 15, 2021
A growing pipeline of gene therapy candidates aimed at treating neurodegenerative diseases has prompted new guidance.
March 12, 2021
This agreement enhances GSK’s investment in cell and gene therapy manufacturing in the UK for clinical trials.
March 01, 2021
The companies intend to design and implement algorithms for the early stages of research for drug discovery and development of drug candidates to treat Alzheimer’s disease.
The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.
February 17, 2021
The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.
Salipro Biotech has been granted a European Patent for its novel method of direct extraction of membrane proteins and for the generation of libraries with Salipro particles.